Limb-Girdle Muscular Dystrophy Type 1B
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Limb-Girdle Muscular Dystrophy Type 1B

What is the definition of Limb-Girdle Muscular Dystrophy Type 1B?
Limb-girdle muscular dystrophy type 1B (LGMD1B) is one of many types of limb-girdle muscular dystrophy. These diseases affect the voluntary muscles, which are the muscles that are moved on purpose, such as the arms, legs, fingers, toes, and facial muscles. Specifically, LGMD1B causes muscle weakness in the lower limbs. The muscle weakness typically affects the muscles closest to the center of the body (proximal muscles) such as the upper legs. Limb-girdle muscular dystrophy type 1B is caused by genetic changes (changes) to the LMNA gene. The disease is inherited in an autosomal dominant manner. A diagnosis of LGMD1B is suspected in people who have signs and symptoms consistent with the disease, and the diagnosis can be confirmed with laboratory tests.
What are the alternative names for Limb-Girdle Muscular Dystrophy Type 1B?
  • Limb-girdle muscular dystrophy type 1B
  • LGMD1B
  • Muscular dystrophy, proximal, type 1B
Who are the top Limb-Girdle Muscular Dystrophy Type 1B Local Doctors?
Distinguished in Limb-Girdle Muscular Dystrophy Type 1B
Family Medicine
Distinguished in Limb-Girdle Muscular Dystrophy Type 1B
Family Medicine

MercyOne Clear Lake Family Medicine

1410 6th Ave. S., 
Clear Lake, IA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Tracy Mixdorf is a primary care provider, practicing in Family Medicine in Clear Lake, Iowa. Dr. Mixdorf is rated as a Distinguished provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 1B. She is also highly rated in 41 other conditions, according to our data. Her clinical expertise encompasses Dystrophinopathy, Limb-Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2B, and Limb-Girdle Muscular Dystrophy Type 1B. Dr. Mixdorf is board certified in Family Medicine, American Board Of Family Medicine and American Board Of Family Medicine. Dr. Mixdorf is currently accepting new patients.

Advanced in Limb-Girdle Muscular Dystrophy Type 1B
Neurology
Advanced in Limb-Girdle Muscular Dystrophy Type 1B
Neurology
Referral may be required

Fletcher Allen Health Care Inc

1 S Prospect St, 
Burlington, VT 
Languages Spoken:
English, Hindi
Offers Telehealth

Rup Tandan is a Neurologist practicing medicine in Burlington, Vermont. Dr. Tandan is rated as an Advanced provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 1B. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myasthenia Gravis, Dysferlinopathy, Primary Lateral Sclerosis, and Thymectomy. Dr. Tandan is board certified in American Board Of Psychiatry And Neurology - Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Limb-Girdle Muscular Dystrophy Type 1B
Advanced in Limb-Girdle Muscular Dystrophy Type 1B
Referral required

Vanderbilt Medical Group- Teleneurology

1161 21st Ave South, A-0118 Medical Center North, 
Nashville, TN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Christopher Lee is a Neurologist practicing medicine in Nashville, Tennessee. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 1B. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Guillain-Barre Syndrome, and Gamma Knife Radiosurgery. Dr. Lee is board certified in American Board Of Psychiatry & Neurology. Dr. Lee is currently accepting new patients.

What are the latest Limb-Girdle Muscular Dystrophy Type 1B Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center